WASHINGTON — The FDA approved the first generic version of the Proventil HFA albuterol inhaler, citing increased demand for this type of product as a treatment for COVID-19.
The metered dose inhaler, made by Cipla Ltd., delivers 90 μg albuterol sulfate per puff; the approved indication is for “treatment or prevention of bronchospasm in patients four years of age and older who have reversible obstructive airway disease, as well as the prevention of exercise-induced bronchospasm in this age group,” according to an FDA statement.
“The FDA recognizes the increased demand for albuterol products during the novel coronavirus pandemic,” said FDA Commissioner Stephen M. Hahn, MD, in the statement.
On March 20, the American College of Allergy, Asthma, and Immunology warned of albuterol inhaler shortages in some parts of the country, “because of the increased use of albuterol inhalers in hospitals for COVID-19 and suspected COVID-19 patients to help with respiratory issues.”
Related Post
Mar
10 Yoga Poses to Boost the Immune System
As the days get more limited and temperatures decrease, we might have seen our schedules are advising us that the Christmas season is quick drawing nearer. That additionally implies that cold and influenza season is back! Yet again sadly for.
Read MoreMar
7 Health Benefits of Attending Concerts
Music resembles an embrace for your spirit. Music is quite possibly of the best gift we have on this planet. It assists us with communicating our feelings, it interfaces with others, and it could actually help us unwind and ease.
Read MoreMar
Why Are Cancer Rates Rising in Adults Under 50?
One of the most widely recognized risk factors for disease is something we can't hope to make any significant difference with age. Our disease risk increments as we age, with the typical age at conclusion drifting around 68. Yet, another concentrate.
Read MoreFeb
World Mental Health Day 2023
World Emotional wellness Day 2023 is a chance for individuals and networks to join behind the subject 'Psychological well-being is a general basic freedom" to further develop information, bring issues to light and drive activities that advance and safeguard everybody's.
Read More